Work

A Phase III, Multicenter, Randomized, Double-Blind, Placebo Controlled, Comparative Trial of AMD3100 (Plerixafor)+G-CSF vs. Placebo+G-CSF in Non-Hodgkin’s Lymphoma (NHL) Patients for Autologous Hematopoietic Stem Cell (aHSC) Transplantation.

Year: 2007

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.601.601

Authors: John F. DiPersio, Ivana Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard Thomas Maziarz, J. Angell, G. Bridger, Gary Calandra, 3101 Investigators7

Institutions: Washington University in St. Louis, Mayo Clinic, Loyola University Chicago, Cleveland Clinic, Oregon Health & Science University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590800135

FWCI: 4.23

Cites:

Cited by: 26

Related to: 10